Cosmo Bio USA offers a scientifically validated Media & Supplements portfolio tailored to support a wide range of cell culture applications—from basic research to clinical and translational development. Cosmo Bio Co., Ltd. provides specialized media such as KBM 591 for mammalian cells, KBM ADSC-5 for mesenchymal stem cell expansion, KBM VEC-1 for vascular endothelial cells, and KBM EV Pure for high-yield exosome production, along with supplements optimized for neuronal culture and cryopreservation. Ajinomoto enhances the lineup with StemFit® and CELLiST™ BASAL CHO MX—animal-origin-free, chemically defined media for iPS/ES cell culture and high-efficiency CHO cell production. KOHJIN BIO supplies the KBM 500 series for lymphocyte and T-cell activation and expansion under serum-free conditions.
Cellular Engineering Technologies (CET) further expands the portfolio with xeno-free, defined media systems for maintaining and differentiating human iPSCs and primary cells, ideal for regenerative medicine, disease modeling, and cell therapy manufacturing. Additional contributions include Primary Cell Co., Ltd. (PMC) with cardiomyocyte-specific media and GIST-T1 tumor-derived cell lines for oncology research. KYOKUTO Pharmaceutical offers CP-1® High Grade cryoprotectant and Stem-Partner® ACF feeder-free media for iPS/ES cell culture. KOHJIN BIO’s COSMEDIUM 005 supports high-density hybridoma culture, while the COS Banker series ensures effective cryopreservation. The Biotherapy Institute of Japan (BIJ) adds the BINKIT®—a robust feeder-free NK cell expansion kit. Koken complements the offering with collagen-based biomaterials like Type II Collagen, Atelocollagen Permeable Membranes, and Collagen Microspheres for 3D culture. Together, these solutions empower researchers with reproducible, scalable tools to advance life science, immunotherapy, and biomanufacturing breakthroughs.